NEW YORK, February 5, 2018 /PRNewswire/ --
Global Market Study on Clostridium Difficile Infection Treatment: FidaxomicinDrug Type to Witness Rapid Adoption in the Near Future
The global clostridium difficile infection treatment market is expected to witness robust growth between 2017 and 2025. This growth is expected to be primarily driven by an increasing adoption
(Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO )
Global Clostridium Difficile Infection Treatment Market Research Report Overview @ https://www.persistencemarketresearch.com/market-research/clostridium-difficile-infection-treatment-market.asp
Global Clostridium Difficile Infection Treatment Market: Trends
Metronidazole, fidoxamycin and vancomycin are some of the commonly prescribed medicines for clostridium difficile infection treatment. The trends observed in the prescriptions of these medicines are different across the word owing to variations in the recurrence of clostridium difficile infections after treatment with each of these drugs. In the U.S., metronidazole is recommended as a first line treatment followed by a combination of vancomycin and fidaxomycin. In Western countries such as the U.S., Canada and several European countries, use of antibiotics has surged in the last two decades. Consequently, the incidents of clostridium difficile infection has increased in these regions.
Global Clostridium Difficile Infection Treatment Market: Forecast by Route of Administration
On the basis of route of administration, the global clostridium difficile infection treatment market is segmented into oral and injectable segments. The injectable segment is expected to witness significant growth over the forecast period with a CAGR of 7.1%. This segment is anticipated to record a market attractiveness index of 0.9.
Request Sample Report@ https://www.persistencemarketresearch.com/samples/15775
Global Clostridium Difficile Infection Treatment Market: Forecast by Distribution Channel
On the basis of distribution channel, the global clostridium difficile infection treatment market is segmented into hospital pharmacies, retail pharmacies and mail order pharmacies. Retail pharmacies are expected to be the most lucrative distribution channel with a market attractiveness index of 1.3. In terms of growth, mail order pharmacies is ahead with a CAGR of 7.2%.
Global Clostridium Difficile Infection Treatment Market: Forecast by Drug Type
On the basis of drug type, the global clostridium difficile infection treatment market is segmented into Metronidazol, Vancomycin and Fidaxomicin. Vancomycin is projected to register steady growth over the forecast period with a CAGR of 6.3%.
Download and View Report TOC, Figures and Tables @ https://www.persistencemarketresearch.com/market-research/clostridium-difficile-infection-treatment-market/toc
Global Clostridium Difficile Infection Treatment Market: Forecast by Region
North America is expected to be the most lucrative market for manufacturers in the global clostridium difficile infection treatment market. The North America clostridium difficile infection treatment market is projected to expand at a growth rate of 6.1%. A conducive business environment in emerging markets like the Asia Pacific coupled with a surge in local production of generic clostridium difficile infection treatment drugs are driving revenue growth of the Asia Pacific clostridium difficile infection treatment market.
Global Clostridium Difficile Infection Treatment Market: Competitive Landscape
Some of the top companies operating in the global market for clostridium difficile infection treatment include Merck & Co. Inc., Baxter International Inc., Sanofi S.A., Pfizer Inc., Novartis AG, Astellas Pharma, Eli Lilly and Company, AstraZeneca Plc., Actelion Pharmaceuticals Ltd (Sub. of Johnson & Johnson Services, Inc.) and Mylan.
Get full Report Now @ https://www.persistencemarketresearch.com/checkout/15775
Persistence Market Research Overview
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Persistence Market Research U.S. Sales Office: 305 Broadway, 7th Floor New York City, NY 10007 +1-646-568-7751 United States USA - Canada Toll-Free: 800-961-0353 Email: email@example.com
PMR Latest News:https://www.persistencemarketresearch.com/news
SOURCE Persistence Market Research Pvt. Ltd.
Subscribe to our Free Newsletters!